Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stanley Golovac

Interventional Pain Medicine Merritt Island, FL Medical Doctor

NPI 1063420610 CMS profile 47512

595 N Courtenay Pkwy, Suite 101, Merritt Island, FL 32953

Open in the dashboard

General payments

$366,531

371 records reported · program years 2019–2025

Research payments

$8,240

Paid to them · 17 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stanley Golovac of Merritt Island, FL is reported in the CMS Open Payments database as having received $366,531 across 371 general payments and $8,240 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,812 20
2024 General $40,063 79
2024 Research $225 1
2023 General $41,373 64
2023 Research $900 1
2022 General $69,957 75
2022 Research $675 1
2021 General $34,553 29
2021 Research $1,125 3
2020 General $21,790 30
2020 Research $2,933 6
2019 General $149,983 74
2019 Research $2,382 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stanley Golovac
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Stanley Golovac were reported at $8,812. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Stanley Golovac Interventional Pain Medicine median Middle half National median
2019 $149,983 $684 $216–$2,079 $163
2020 $21,790 $382 $122–$1,109 $114
2021 $34,553 $552 $167–$1,554 $132
2022 $69,957 $605 $187–$1,924 $149
2023 $41,373 $671 $195–$1,915 $160
2024 $40,063 $684 $206–$1,837 $164
2025 $8,812 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vertos Medical, Inc. $291,651 201 payments
  2. Abbott Laboratories $42,882 98 payments
  3. Medtronic, Inc. $12,581 17 payments
  4. Stryker Corporation $11,850 25 payments
  5. Epimed International, Inc $4,630 12 payments
  6. Spinal Simplicity, LLC $1,147 1 payment
  7. Boston Scientific Corporation $1,104 9 payments
  8. Nevro Corp. $242 2 payments
  9. Stimwave Technologies Incorporated $117 1 payment
  10. SPR Therapeutics, Inc $116 1 payment
  11. Other $210 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $197,888 114 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $98,950 10 payments
  3. Travel and Lodging $44,076 82 payments
  4. Food and Beverage $11,298 147 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $9,188 5 payments
  6. Royalty or License $4,630 12 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $500 1 payment
Products named General payments · program years 2019–2025
  1. mild Device Kit Orthopedic $150,996 71 payments
  2. mild Device Kit Orthopedic $140,655 130 payments
  3. PROCLAIM Neuromodulation $12,821 21 payments
  4. Accurian $12,244 10 payments
  5. Neuromodulation Dspsbls and Accs $10,107 6 payments
  6. MILD DEVICE KIT Instruments $6,208 14 payments
  7. Proclaim Family of SCS IPGs $6,036 12 payments
  8. PROCLAIM Neuromodulation $4,707 24 payments
  9. Protege Family of SCS IPGs $3,348 3 payments
  10. Catheters and Needles $3,302 6 payments
  11. Other $12,441 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Vertos Medical, Inc. $7,988 14 payments
  2. Saluda Medical Americas, Inc. $253 3 payments

Records

388 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record